Director/PDMR Shareholding

RNS Number : 3495O

Circassia Pharmaceuticals Plc

01 October 2019

 

Director/PDMR Shareholding

Oxford, UK - 1 October 2019: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces that on 30 September 2019, Jonathan Emms, Chief Operating Officer of Circassia, purchased 300,000 Ordinary Shares on the London Stock Exchange at a price of 16.5 pence per share.

Contacts

Circassia Steve Harris, Chief Executive Officer Julien Cotta, Chief Financial Officer Rob Budge, Corporate Communications	Tel: [phone]
Peel Hunt (Nominated Adviser and Joint Broker) James Steel / Dr Christopher Golden	Tel: [phone]
finnCap (Joint Broker) Geoff Nash / Alice Lane	Tel: [phone]
Numis Securities (Joint Broker) James Black / Freddie Barnfield	Tel: [phone]
FTI Consulting Simon Conway / Ciara Martin	Tel: [phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Jonathan Emms
2.	Reason for the notification
a.	Position/status	Chief Operating Officer
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Circassia Pharmaceuticals plc
b.	LEI	2138006YAT138TOGA556
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary Shares of 0.08p each GB00BJVD3B28
b.	Nature of the transaction	Purchase of Ordinary Shares
c.	Price(s) and volume(s)	Price(s) Volume(s) 16.5147p 300,000
d.	Aggregated information ·      Aggregated volume ·      Price	n/a
e.	Date of the transaction	2019-09-30
f.	Place of the transaction	London Stock Exchange, AIM

 

END

 

 

DSHBGBDGGDGBGCB